Proteomics-Informed Prediction of Rosuvastatin Plasma Profiles in Patients with a Wide Range of Body Weight

导出原文传递

翻译打印收藏纠错

作者： Wegler, Christine ^[1] ; Garcia, Luna Prieto ^[2] ; Klinting, Signe ^[3] ; Robertsen, Ida ^[4] ; Wisniewski, Jacek R. ^[5] ; Hjelmesaeth, Joran ; Asberg, Anders ; Jansson-Lofmark, Rasmus ; Andersson, Tommy B. ; Artursson, Per

作者单位： Max Planck Inst Biochem, Dept Prote & Signal Transduct, Biochem Prote Grp, Martinsried, Germany ^[1] Univ Oslo, Dept Pharm, Oslo, Norway ^[2] Uppsala Univ, Dept Pharm, Uppsala, Sweden ^[3] Vestfold Hosp Trust, Morbid Obes Ctr, Dept Med, Tonsberg, Norway ^[4] AstraZeneca, BioPharmaceut R&D, DMPK, Res & Early Dev Cardiovasc,Renal & Metab, Gothenburg, Sweden ^[5]

发布时间 2021-07-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Clinical Pharmacology and Therapeutics

2021年109卷3期

762-771页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Proteomics-Informed Prediction of Rosuvastatin Plasma Profiles in Patients with a Wide Range of Body Weight

Clinical Pharmacology and Therapeutics

相似文献

Clinical Pharmacology and Therapeutics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Proteomics-Informed Prediction of Rosuvastatin Plasma Profiles in Patients with a Wide Range of Body Weight

Clinical Pharmacology and Therapeutics

相似文献

Clinical Pharmacology and Therapeutics

相关期刊

检索历史清除